Lista de obras -

A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy

artículo científico publicado en 2020

A Comprehensive Approach to Pouch Disorders

artículo científico publicado en 2019

A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community

artículo científico publicado en 2013

A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy

artículo científico publicado en 2016

A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares

artículo científico publicado en 2020

AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation

artículo científico publicado en 2018

An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study

scientific article published on 01 April 2019

An Update on the Medical Management of Inflammatory Pouch Complications

artículo científico publicado en 2020

Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients

scientific article published on 18 January 2019

Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study

artículo científico publicado en 2017

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

artículo científico publicado en 2019

Appropriateness of Combination Therapy in Inflammatory Bowel Disease: One Size Still Does Not Fit All.

artículo científico publicado en 2018

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

artículo científico publicado en 2016

Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?

scientific article published on 01 November 2019

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement

artículo científico publicado en 2018

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center

scientific article published on 14 February 2020

Comparison of brush and biopsy sampling methods of the ileal pouch for assessment of mucosa-associated microbiota of human subjects

artículo científico publicado en 2014

Crohn's Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era.

artículo científico publicado en 2015

Crohn's Disease of the Pouch: A True Diagnosis or an Oversubscribed Diagnosis of Exclusion?

artículo científico publicado en 2017

Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes

artículo científico publicado en 2013

De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center

artículo científico publicado en 2019

De-novo Inflammatory bowel disease after bariatric surgery: a large case series

artículo científico publicado en 2017

Depression Is Associated With More Aggressive Inflammatory Bowel Disease

artículo científico publicado en 2017

Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States

artículo científico publicado en 2020

Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States

artículo científico publicado en 2020

Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise? Authors' reply

scientific article published on 01 September 2018

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials

artículo científico

Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

scientific article published on 28 May 2018

Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort

scientific article published on 01 August 2019

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial

artículo científico publicado en 2018

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients

artículo científico publicado en 2014

Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease

scientific article published on 15 October 2019

Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset

artículo científico publicado en 2017

Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility

artículo científico publicado en 2016

Ipilimumab-induced colitis in patients with metastatic melanoma

artículo científico publicado en 2015

Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's Disease

artículo científico publicado en 2017

Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.

artículo científico publicado en 2013

Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis

artículo científico publicado en 2018

Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel

artículo científico publicado en 2016

Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease

artículo científico publicado en 2017

Nonrelaxing Pelvic Floor Dysfunction Is an Underestimated Complication of Ileal Pouch-Anal Anastomosis

artículo científico publicado en 2017

Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease

scientific article published on 01 August 2019

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease

artículo científico publicado en 2017

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease

artículo científico publicado en 2016

Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations

artículo científico publicado en 2017

Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis

artículo científico publicado en 2016

Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis

artículo científico publicado en 2017

Program Directors' Perspectives of Gastroenterology and Hepatology Fellowship Application

artículo científico publicado en 2020

Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment tool

artículo científico publicado en 2019

RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS

artículo científico publicado en 2021

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.

artículo científico publicado en 2016

Response to Dai et al. and Gracie et al

artículo científico publicado en 2018

Response to Levenstein and Prantera

artículo científico publicado en 2018

Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis

artículo científico publicado en 2017

Role of intestinal bacteria in the pathogenesis of pouchitis

artículo científico publicado en 2014

Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.

artículo científico

Submucosal Vascular Malformation as the Cause of Recurrent Obscure Bleed

scientific article published on 14 May 2019

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis

artículo científico publicado en 2017

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

artículo científico publicado en 2018

The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis

scientific article published on 05 August 2019

The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients

artículo científico publicado en 2022

The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study

artículo científico publicado en 2020

The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies

artículo científico publicado en 2017

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease

artículo científico publicado en 2017

Tuberculosis of the gastrointestinal tract and associated viscera

scientific article published on 14 April 2018

Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience

scientific article published on 01 April 2020

Use of immune checkpoint inhibitors in patients with pre-established inflammatory bowel diseases: retrospective case series

scientific article published on 18 June 2020

Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort

artículo científico publicado en 2019

Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States

artículo científico publicado en 2014

Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease

scientific article published on 01 February 2019

Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis.

artículo científico publicado en 2018

Vedolizumab in the Perioperative Management of Inflammatory Bowel Disease

artículo científico publicado en 2019

Lista de obras de

A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy

A Comprehensive Approach to Pouch Disorders

A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community

A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy

A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares

AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation

An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study

An Update on the Medical Management of Inflammatory Pouch Complications

Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients

Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

Appropriateness of Combination Therapy in Inflammatory Bowel Disease: One Size Still Does Not Fit All.

Appropriateness of Testing for Anti-Tumor Necrosis Factor Agent and Antibody Concentrations, and Interpretation of Results

Biologics and 30-Day Postoperative Complications After Abdominal Operations for Crohn's Disease: Are There Differences in the Safety Profiles?

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center

Comparison of brush and biopsy sampling methods of the ileal pouch for assessment of mucosa-associated microbiota of human subjects

Crohn's Disease of the Esophagus: Clinical Features and Treatment Outcomes in the Biologic Era.

Crohn's Disease of the Pouch: A True Diagnosis or an Oversubscribed Diagnosis of Exclusion?

Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes

De Novo Colitis Associated With Rituximab in 21 Patients at a Tertiary Center

De-novo Inflammatory bowel disease after bariatric surgery: a large case series

Depression Is Associated With More Aggressive Inflammatory Bowel Disease

Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States

Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States

Editorial: biologic therapies for primary sclerosing cholangitis-more disappointment than promise? Authors' reply

Effects of Concomitant Immunomodulator Therapy on Efficacy and Safety of Anti-Tumor Necrosis Factor Therapy for Crohn's Disease: A Meta-analysis of Placebo-controlled Trials

Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial

Idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease: retrospective analysis of 9095 patients

Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease

Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset

Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility

Ipilimumab-induced colitis in patients with metastatic melanoma

Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's Disease

Letter: Effectiveness of split-dose certolizumab pegol for Crohn's disease.

Natural History of Established and De Novo Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis

Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel

Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease

Nonrelaxing Pelvic Floor Dysfunction Is an Underestimated Complication of Ileal Pouch-Anal Anastomosis

Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease

Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease

Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease

Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations

Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis

Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis

Program Directors' Perspectives of Gastroenterology and Hepatology Fellowship Application

Prospective multicenter study to evaluate capsule endoscopy competency using a validated assessment tool

RISK FACTORS FOR OUTCOMES OF PATIENTS WITH HISTOLOGICALLY PROVEN CHECKPOINT-INHIBITOR COLITIS

Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.

Response to Dai et al. and Gracie et al

Response to Levenstein and Prantera

Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis

Role of intestinal bacteria in the pathogenesis of pouchitis

Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.

Submucosal Vascular Malformation as the Cause of Recurrent Obscure Bleed

Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis

Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease

The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis

The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients

The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study

The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease

Tuberculosis of the gastrointestinal tract and associated viscera

Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience

Use of immune checkpoint inhibitors in patients with pre-established inflammatory bowel diseases: retrospective case series

Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort

Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States

Vedolizumab Drug Level Correlation With Clinical Remission, Biomarker Normalization, and Mucosal Healing in Inflammatory Bowel Disease

Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis.

Vedolizumab in the Perioperative Management of Inflammatory Bowel Disease